Concepts (100)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pre-Exposure Prophylaxis | 7 | 2019 | 53 | 2.110 |
Why?
|
| HIV Infections | 10 | 2019 | 2023 | 1.240 |
Why?
|
| Patient Acceptance of Health Care | 4 | 2019 | 480 | 0.680 |
Why?
|
| Disease Transmission, Infectious | 2 | 2018 | 87 | 0.670 |
Why?
|
| Homosexuality, Male | 6 | 2025 | 72 | 0.650 |
Why?
|
| Sexual and Gender Minorities | 5 | 2025 | 72 | 0.620 |
Why?
|
| Health Plan Implementation | 1 | 2018 | 44 | 0.560 |
Why?
|
| Oropharyngeal Neoplasms | 3 | 2025 | 285 | 0.500 |
Why?
|
| Program Evaluation | 1 | 2018 | 459 | 0.490 |
Why?
|
| Papillomavirus Infections | 3 | 2025 | 398 | 0.460 |
Why?
|
| Consumer Behavior | 1 | 2014 | 37 | 0.450 |
Why?
|
| Health Knowledge, Attitudes, Practice | 6 | 2025 | 904 | 0.410 |
Why?
|
| Mass Screening | 1 | 2015 | 833 | 0.300 |
Why?
|
| Bisexuality | 2 | 2025 | 13 | 0.290 |
Why?
|
| Emergency Service, Hospital | 1 | 2015 | 1166 | 0.270 |
Why?
|
| Texas | 5 | 2019 | 3668 | 0.260 |
Why?
|
| Anti-HIV Agents | 3 | 2019 | 343 | 0.250 |
Why?
|
| Urban Population | 3 | 2019 | 244 | 0.240 |
Why?
|
| Tobacco Use | 1 | 2025 | 31 | 0.230 |
Why?
|
| Early Detection of Cancer | 2 | 2025 | 414 | 0.210 |
Why?
|
| Alcohol Drinking | 1 | 2025 | 361 | 0.190 |
Why?
|
| Social Networking | 2 | 2019 | 18 | 0.180 |
Why?
|
| Young Adult | 7 | 2019 | 9980 | 0.160 |
Why?
|
| Adult | 11 | 2025 | 31787 | 0.150 |
Why?
|
| Qualitative Research | 3 | 2019 | 659 | 0.140 |
Why?
|
| Sexual Partners | 2 | 2018 | 85 | 0.140 |
Why?
|
| Health Services Administration | 1 | 2018 | 11 | 0.140 |
Why?
|
| Health Personnel | 1 | 2023 | 549 | 0.140 |
Why?
|
| Chemoprevention | 1 | 2018 | 54 | 0.140 |
Why?
|
| Syphilis | 1 | 2018 | 98 | 0.130 |
Why?
|
| Health Services Research | 1 | 2018 | 190 | 0.130 |
Why?
|
| Middle Aged | 7 | 2025 | 29081 | 0.120 |
Why?
|
| Viral Load | 1 | 2018 | 407 | 0.120 |
Why?
|
| Coinfection | 1 | 2018 | 184 | 0.120 |
Why?
|
| Hospitals, Urban | 1 | 2015 | 99 | 0.110 |
Why?
|
| Health Behavior | 1 | 2018 | 400 | 0.110 |
Why?
|
| Boston | 1 | 2014 | 122 | 0.110 |
Why?
|
| Condoms | 1 | 2014 | 52 | 0.110 |
Why?
|
| Male | 11 | 2025 | 65657 | 0.110 |
Why?
|
| Meningoencephalitis | 1 | 2014 | 22 | 0.110 |
Why?
|
| Adolescent | 6 | 2019 | 20605 | 0.110 |
Why?
|
| Focus Groups | 1 | 2014 | 215 | 0.110 |
Why?
|
| Health Services Accessibility | 3 | 2019 | 658 | 0.100 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2014 | 237 | 0.100 |
Why?
|
| Humans | 15 | 2025 | 133529 | 0.100 |
Why?
|
| Cross-Sectional Studies | 4 | 2025 | 3758 | 0.090 |
Why?
|
| Socioeconomic Factors | 1 | 2014 | 911 | 0.090 |
Why?
|
| Female | 9 | 2019 | 71560 | 0.080 |
Why?
|
| Chagas Disease | 1 | 2014 | 309 | 0.080 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2009 | 55 | 0.080 |
Why?
|
| AIDS Serodiagnosis | 1 | 2009 | 57 | 0.070 |
Why?
|
| Uncompensated Care | 1 | 2008 | 12 | 0.070 |
Why?
|
| Social Work | 1 | 2008 | 21 | 0.070 |
Why?
|
| Labor, Obstetric | 1 | 2009 | 97 | 0.070 |
Why?
|
| Preceptorship | 1 | 2008 | 31 | 0.070 |
Why?
|
| HIV Seropositivity | 1 | 2009 | 128 | 0.070 |
Why?
|
| Risk-Taking | 2 | 2018 | 102 | 0.070 |
Why?
|
| Medically Underserved Area | 1 | 2008 | 93 | 0.070 |
Why?
|
| Community Health Services | 1 | 2008 | 93 | 0.070 |
Why?
|
| Prospective Studies | 1 | 2018 | 6586 | 0.070 |
Why?
|
| Vulnerable Populations | 1 | 2008 | 148 | 0.060 |
Why?
|
| Hospitals | 1 | 2009 | 442 | 0.060 |
Why?
|
| Cohort Studies | 1 | 2015 | 5205 | 0.060 |
Why?
|
| Students, Medical | 1 | 2008 | 364 | 0.050 |
Why?
|
| United States | 4 | 2019 | 11761 | 0.050 |
Why?
|
| Primary Health Care | 1 | 2008 | 804 | 0.050 |
Why?
|
| Retrospective Studies | 2 | 2018 | 17579 | 0.040 |
Why?
|
| Aged | 1 | 2018 | 21584 | 0.040 |
Why?
|
| Los Angeles | 1 | 2019 | 16 | 0.040 |
Why?
|
| Safe Sex | 1 | 2019 | 15 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2023 | 1463 | 0.040 |
Why?
|
| New Jersey | 2 | 2009 | 25 | 0.040 |
Why?
|
| Cities | 1 | 2018 | 51 | 0.040 |
Why?
|
| Surveys and Questionnaires | 2 | 2019 | 3990 | 0.040 |
Why?
|
| Social Stigma | 1 | 2019 | 84 | 0.040 |
Why?
|
| Health Surveys | 1 | 2019 | 259 | 0.040 |
Why?
|
| Chicago | 1 | 2018 | 21 | 0.040 |
Why?
|
| Trust | 1 | 2019 | 82 | 0.040 |
Why?
|
| Tablets | 1 | 2018 | 36 | 0.040 |
Why?
|
| Epidemics | 1 | 2018 | 59 | 0.030 |
Why?
|
| Risk Factors | 2 | 2025 | 10970 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 2019 | 429 | 0.030 |
Why?
|
| Sexual Behavior | 1 | 2018 | 250 | 0.030 |
Why?
|
| Social Support | 1 | 2018 | 388 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2019 | 573 | 0.030 |
Why?
|
| Toxoplasmosis, Cerebral | 1 | 2014 | 5 | 0.030 |
Why?
|
| Medication Adherence | 1 | 2018 | 340 | 0.030 |
Why?
|
| Trypanocidal Agents | 1 | 2014 | 31 | 0.030 |
Why?
|
| Nitroimidazoles | 1 | 2014 | 44 | 0.030 |
Why?
|
| Logistic Models | 1 | 2018 | 1870 | 0.020 |
Why?
|
| Trypanosoma cruzi | 1 | 2014 | 251 | 0.020 |
Why?
|
| Prevalence | 1 | 2018 | 2678 | 0.020 |
Why?
|
| Appointments and Schedules | 1 | 2008 | 50 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 1973 | 0.020 |
Why?
|
| Program Development | 1 | 2008 | 190 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2008 | 336 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 2009 | 1206 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2014 | 13101 | 0.010 |
Why?
|
| Pregnancy | 1 | 2009 | 7598 | 0.010 |
Why?
|
| Child | 1 | 2008 | 25888 | 0.000 |
Why?
|